5-Bromo-4,6-dihydroxypyrimidine
CAS: 15726-38-2
Ref. 3D-FB12051
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
5-Bromo-4,6-dihydroxypyrimidine
Sinónimos:
- 5-bromo-6-hydroxypyrimidin-4(3H)-one
Descrição:
5-Bromo-4,6-dihydroxypyrimidine is a potent inhibitor of the enzyme uridine phosphorylase. This enzyme catalyzes the conversion of uridine to UMP and water. The enzyme also has decarboxylase activity, which converts UMP to IMP. The inhibitory effects of 5-bromo-4,6-dihydroxypyrimidine on this enzyme are likely due to its ability to bind to the active site of the enzyme and form a covalent bond with the substrate. 5-Bromo-4,6-dihydroxypyrimidine is used as an experimental treatment for giardia infections in vitro culture and has been shown to be effective against giardia lamblia. It has also been shown that this drug blocks nitric oxide synthase (NOS) activity in giardia lamblia and prevents nitric oxide synthesis as well as NADH oxidation.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
190.98 g/mol
Fórmula:
C4H3BrN2O2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
